NEW YORK (GenomeWeb News) – London-based venture capital firm Advent Venture Partners today announced the final close of a £75 million ($118 million) life science VC fund.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.